Literature DB >> 23795673

Synthesis and antiprotozoal activity of dicationic m-terphenyl and 1,3-dipyridylbenzene derivatives.

Donald A Patrick1, Mohamed A Ismail, Reem K Arafa, Tanja Wenzler, Xiaohua Zhu, Trupti Pandharkar, Susan Kilgore Jones, Karl A Werbovetz, Reto Brun, David W Boykin, Richard R Tidwell.   

Abstract

4,4″-Diamidino-m-terphenyl (1) and 36 analogues were prepared and assayed in vitro against T rypanosoma brucei rhodesiense , Trypanosoma cruzi , Plasmodium falciparum , and Leishmania amazonensis . Twenty-three compounds were highly active against T. b. rhodesiense or P. falciparum. Most noteworthy were amidines 1, 10, and 11 with IC50 of 4 nM against T. b. rhodesiense, and dimethyltetrahydropyrimidinyl analogues 4 and 9 with IC50 values of ≤ 3 nM against P. falciparum. Bis-pyridylimidamide derivative 31 was 25 times more potent than benznidazole against T. cruzi and slightly more potent than amphotericin B against L. amazonensis. Terphenyldiamidine 1 and dipyridylbenzene analogues 23 and 25 each cured 4/4 mice infected with T. b. rhodesiense STIB900 with four daily 5 mg/kg intraperitoneal doses, as well as with single doses of ≤ 10 mg/kg. Derivatives 5 and 28 (prodrugs of 1 and 25) each cured 3/4 mice with four daily 25 mg/kg oral doses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23795673     DOI: 10.1021/jm400508e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

2.  Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense.

Authors:  Donald A Patrick; Tanja Wenzler; Sihyung Yang; Patrick T Weiser; Michael Zhuo Wang; Reto Brun; Richard R Tidwell
Journal:  Bioorg Med Chem       Date:  2016-04-02       Impact factor: 3.641

3.  In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.

Authors:  Tanja Wenzler; Sihyung Yang; Donald A Patrick; Olivier Braissant; Mohamed A Ismail; Richard R Tidwell; David W Boykin; Michael Zhuo Wang; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  In Vitro, In Silico, and In Vivo Analyses of Novel Aromatic Amidines against Trypanosoma cruzi.

Authors:  Camila C Santos; Jéssica R Lionel; Raiza B Peres; Marcos M Batista; Patrícia B da Silva; Gabriel M de Oliveira; Cristiane F da Silva; Denise G J Batista; Sandra Maria O Souza; Carolina H Andrade; Bruno J Neves; Rodolpho C Braga; Donald A Patrick; Svetlana M Bakunova; Richard R Tidwell; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

5.  Activity of diimidazoline amides against African trypanosomiasis.

Authors:  Yuxiang Dong; Xiaofang Wang; Monica Cal; Marcel Kaiser; Jonathan L Vennerstrom
Journal:  Bioorg Med Chem Lett       Date:  2013-12-22       Impact factor: 2.823

6.  Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.

Authors:  Lucas N Alberca; María L Sbaraglini; Darío Balcazar; Laura Fraccaroli; Carolina Carrillo; Andrea Medeiros; Diego Benitez; Marcelo Comini; Alan Talevi
Journal:  J Comput Aided Mol Des       Date:  2016-02-18       Impact factor: 3.686

7.  In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.

Authors:  F H Guedes-da-Silva; D G J Batista; M B Meuser; K C Demarque; T O Fulco; J S Araújo; P B Da Silva; C F Da Silva; D A Patrick; S M Bakunova; S A Bakunov; R R Tidwell; G M Oliveira; C Britto; O C Moreira; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 8.  Novel lead compounds in pre-clinical development against African sleeping sickness.

Authors:  Michael Berninger; Ines Schmidt; Alicia Ponte-Sucre; Ulrike Holzgrabe
Journal:  Medchemcomm       Date:  2017-07-31       Impact factor: 3.597

9.  Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.

Authors:  Xiaohua Zhu; Abdelbasset A Farahat; Meena Mattamana; April Joice; Trupti Pandharkar; Elizabeth Holt; Moloy Banerjee; Jamie L Gragg; Laixing Hu; Arvind Kumar; Sihyung Yang; Michael Zhuo Wang; David W Boykin; Karl A Werbovetz
Journal:  Bioorg Med Chem Lett       Date:  2016-03-25       Impact factor: 2.823

Review 10.  Recent Advances in the Discovery of Novel Antiprotozoal Agents.

Authors:  Seong-Min Lee; Min-Sun Kim; Faisal Hayat; Dongyun Shin
Journal:  Molecules       Date:  2019-10-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.